Literature DB >> 11430901

Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke.

G M Bishop1, S R Robinson.   

Abstract

Iron that is not bound to storage proteins can catalyse the generation of toxic hydroxyl radicals. Iron can be released from brain storage proteins by hypoxic conditions, such as those that accompany stroke, and the situation can be compounded by iron released from hemoglobin in extravasated blood cells. Despite the neurotoxicity of iron, there is little quantitative data concerning the spatio-temporal extent of its toxicity in vivo. The present study measures the effects of a pathologically relevant concentration of iron (1.0 mM) on neuronal death and on ferritin expression in vivo. Injection of iron (1 microl ferric ammonium citrate) into rat parietal cortex resulted in 7.9-fold more ferritin-labeled cells than did control injections of ammonium citrate at 1 day post-injection. This elevated expression continued for at least 1 week. One day after injection, the mean number of Fluoro-Jade-labeled degenerating neurons in 100 microm sections passing through the center of ferric ammonium citrate injection sites was 664+/-64. This value was 4.5-fold higher than at ammonium citrate injection sites, and this difference increased to 56-fold by day three. By 5 days post-injection, few dying neurons were observed at the control sites, but neurodegeneration continued beyond a week at the iron-injected sites. Thus, iron released during a brief episode of hypoxia-ischemia or during a stroke may be neurotoxic for a protracted period. Therefore, our findings indicate that it may be beneficial to target iron-induced peroxidation throughout the first few weeks following an intracerebral hemorrhage or an hypoxic-ischemic episode.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430901     DOI: 10.1016/s0006-8993(01)02303-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  43 in total

1.  Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury.

Authors:  He Wu; Tao Wu; Mingchang Li; Jian Wang
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

Review 2.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

3.  Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury.

Authors:  Jin-Yul Lee; Richard F Keep; Yangdong He; Oren Sagher; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

4.  Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia.

Authors:  Glenda M Bishop; Theresa N Dang; Ralf Dringen; Stephen R Robinson
Journal:  Neurotox Res       Date:  2010-04-30       Impact factor: 3.911

5.  Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types.

Authors:  J A Lockman; W J Geldenhuys; K A Bohn; S F Desilva; D D Allen; C J Van der Schyf
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

6.  Monitoring of the Cytoskeleton-Dependent Intracellular Trafficking of Fluorescent Iron Oxide Nanoparticles by Nanoparticle Pulse-Chase Experiments in C6 Glioma Cells.

Authors:  Wiebke Willmann; Ralf Dringen
Journal:  Neurochem Res       Date:  2018-09-08       Impact factor: 3.996

7.  Treatment with the iron chelator, deferoxamine mesylate, alters serum markers of oxidative stress in stroke patients.

Authors:  Magdy Selim
Journal:  Transl Stroke Res       Date:  2009-12-10       Impact factor: 6.829

8.  Hemoglobin-induced nitric oxide synthase overexpression and nitric oxide production contribute to blood-brain barrier disruption in the rat.

Authors:  Shuo Yang; Yizhao Chen; Xinqing Deng; Weiping Jiang; Bing Li; Zhenghao Fu; Mouxuan Du; Rui Ding
Journal:  J Mol Neurosci       Date:  2013-03-15       Impact factor: 3.444

9.  Apotransferrin-induced recovery after hypoxic/ischaemic injury on myelination.

Authors:  Mariano Guardia Clausi; Laura A Pasquini; Eduardo F Soto; Juana M Pasquini
Journal:  ASN Neuro       Date:  2010-11-19       Impact factor: 4.146

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.